BioHealth News Archive
Amgen Agrees to Deal to Buy Horizon Therapeutics – WSJ
The U.S. biotechnology company will pay $116.50 for each Horizon share Amgen Inc. has agreed to acquire Horizon Therapeutics PLC in an all-cash deal valued…
Read More
Emmes launches cell and gene therapy centre
Emmes, a global, full-service clinical research organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, has announced the creation of…
Read More
Updated: Gilead, Arcellx team up on anti-BCMA CAR-T as biotech touts a 100% response rate at #ASH22 – Endpoints News
Gilead and Kite are plunking down big cash to get into the anti-BCMA CAR-T game. The pair will shell out $225 million in cash…
Read More
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
REDWOOD CITY, Calif., and SANTA MONICA, Calif., Dec. 9, 2022 /PRNewswire/ -- Arcellx, Inc. (NASDAQ: ACLX) and Kite, a Gilead Company (NASDAQ: GILD), today…
Read More
Maryland Inno – Baltimore biotech Haystack Oncology raises $56M, plans move to City Garage
The Johns Hopkins University researchers behind two of Baltimore's most successful biotech firms have founded a new company that has now raised $56 million…
Read More
New UMD biotech campus to open in Montgomery County in 2023
The University of Maryland is partnering with Montgomery County to develop a new biotech campus near the North Bethesda Metro Station that will open…
Read More
Emmes Launches Cell and Gene Therapy Center
Decades of Experience and Emerging Opportunities Led to its Creation ROCKVILLE, Md., Dec. 8, 2022 /PRNewswire/ -- Emmes, a global, full-service Clinical Research Organization…
Read More
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2023
SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C., December 08, 2022--(BUSINESS WIRE)--United Therapeutics (Nasdaq: UTHR), a public benefit corporation, today announced that the company…
Read More
Emergent BioSolutions Announces U.S. FDA Acceptance and Priority Review of Supplemental New Drug Application for Over-the-Counter NARCAN® (naloxone HCl) Nasal Spray
Emergent’s supplemental new drug application is the first prescription-to-over-the-counter switch application in history to be granted Priority Review by the FDA. NARCAN® (naloxone HCI)…
Read More
DC Inno – Tech transfer program’s mission: Nurture tech-related businesses and retain “highly trained workforce”
University of Maryland College Park (UMCP) graduates are some of the most sought-after graduates in the country – Maryland is the No. 1 state…
Read More
Washingon D.C.’s Vanda Pharmaceuticals Reports Results in a Phase II Clinical Study in the Treatment of Acute Performance Anxiety
WASHINGTON, Dec. 2, 2022 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported results in a Phase II clinical study of VQW-765, a novel small molecule…
Read More
Life depends on this Molecular “Engine” – LinkedIn
3D Model of ATP Synthase - molecular motor (enzyme) that powers cells, generating chemical energy in the form of ATP molecules. The 1997 Nobel…
Read More
Please Join Us: The Midterms Are Over: Implications for Federal Healthcare and Life Sciences Policy (Tuesday, December 6, 2022 | 1:30 p.m. – 2:30 p.m. ET)
Join Venable’s Ari J. Markenson, Ilisa Halpern Paul, and Joshua Raymond in a discussion of the implications for national healthcare and life sciences policy…
Read More
Frederick Maryland Launches Next Biotech Bootcamp and Announces New Program Partner
Maryland Manufacturing Extension Partnership joins City/County consortium to expand third Biotech Bootcamp in Frederick FREDERICK, MD. (PRWEB) DECEMBER 01, 2022 Following the completion of two…
Read More
StockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi
A year marked mostly by biopharma mergers and acquisitions (M&A) in the hundreds of millions of dollars could end with a blockbuster, depending how…
Read More